267 related articles for article (PubMed ID: 30968858)
1. [Opioid-induced constipation in oncologic patient: a clinical case treated with naloxegol].
Gallo P
Recenti Prog Med; 2019 Mar; 110(3):6e-9e. PubMed ID: 30968858
[TBL] [Abstract][Full Text] [Related]
2. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of persistent opioid-induced constipation in patients with hematological malignancies: case report].
Recenti Prog Med; 2018 Nov; 109(11):11e-14e. PubMed ID: 30565581
[TBL] [Abstract][Full Text] [Related]
4. Naloxegol for opioid-induced constipation in patients with noncancer pain.
Chey WD; Webster L; Sostek M; Lappalainen J; Barker PN; Tack J
N Engl J Med; 2014 Jun; 370(25):2387-96. PubMed ID: 24896818
[TBL] [Abstract][Full Text] [Related]
5. Naloxegol to Treat Constipation in a Patient Taking Opioids for Cancer Pain: A Case Report.
Gálvez R; Maire C; Tovar I; Vargas P
A A Pract; 2018 Jul; 11(1):22-24. PubMed ID: 29634552
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
White WB; Kowey P; Diva U; Sostek M; Tummala R
J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
[TBL] [Abstract][Full Text] [Related]
7. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
van Malderen K; Halawi H; Camilleri M
Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
[TBL] [Abstract][Full Text] [Related]
8. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
Webster L; Chey WD; Tack J; Lappalainen J; Diva U; Sostek M
Aliment Pharmacol Ther; 2014 Oct; 40(7):771-9. PubMed ID: 25112584
[TBL] [Abstract][Full Text] [Related]
9. Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation.
Webster L; Diva U; Tummala R; Sostek M
Pain Pract; 2018 Apr; 18(4):505-514. PubMed ID: 28898536
[TBL] [Abstract][Full Text] [Related]
10. Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.
Lawson R; King F; Marsh K; Altincatal A; Cimen A
Adv Ther; 2016 Aug; 33(8):1331-46. PubMed ID: 27342744
[TBL] [Abstract][Full Text] [Related]
11. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
Jones R; Prommer E; Backstedt D
Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation.
Lemaire A; Pointreau Y; Narciso B; Piloquet FX; Braniste V; Sabaté JM
Support Care Cancer; 2021 Dec; 29(12):7577-7586. PubMed ID: 34120247
[TBL] [Abstract][Full Text] [Related]
13. A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced Constipation.
Brenner DM; Hu Y; Datto C; Creanga D; Camilleri M
Am J Gastroenterol; 2019 Jun; 114(6):954-963. PubMed ID: 31058652
[TBL] [Abstract][Full Text] [Related]
14. Naloxegol: a review of its use in patients with opioid-induced constipation.
Garnock-Jones KP
Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
[TBL] [Abstract][Full Text] [Related]
15. Naloxegol for managing opioid-induced constipation.
Shelton KN; Clements JN
JAAPA; 2017 Sep; 30(9):51-53. PubMed ID: 28858018
[TBL] [Abstract][Full Text] [Related]
16. Naloxegol for the treatment of opioid-induced constipation.
Tack J; Corsetti M
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):855-61. PubMed ID: 25220391
[TBL] [Abstract][Full Text] [Related]
17. The impact of naloxegol on anal sphincter function - Using a human experimental model of opioid-induced bowel dysfunction.
Grønlund D; Poulsen JL; Krogh K; Brock C; Liao D; Gregersen H; Drewes AM; Olesen AE
Eur J Pharm Sci; 2018 May; 117():187-192. PubMed ID: 29432808
[TBL] [Abstract][Full Text] [Related]
18. Naloxegol , a new drug for the treatment of opioid-induced constipation.
Corsetti M; Tack J
Expert Opin Pharmacother; 2015 Feb; 16(3):399-406. PubMed ID: 25496063
[TBL] [Abstract][Full Text] [Related]
19. [Management of adverse effects of opioid therapy].
Wirz S
Z Gastroenterol; 2017 Apr; 55(4):394-400. PubMed ID: 28363231
[TBL] [Abstract][Full Text] [Related]
20. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
Holder RM; Rhee D
Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
